Close

Walgreens (WAG) Reports In-Line Q4 EPS; Comps Rose 5.4%

September 30, 2014 7:32 AM EDT

Walgreens (NYSE: WAG) reported Q4 EPS of $0.74, in-line with the analyst estimate of $0.74. Revenue for the quarter came in at $19.1 billion versus the consensus estimate of $19.03 billion.

Total sales in comparable stores increase 5.4 percent.

Front-end comparable store sales (those open at least a year) increased 1.3 percent in the fourth quarter compared with last year’s fourth quarter. Customer traffic in comparable stores decreased 2.2 percent and basket size increased 3.5 percent, while total sales in comparable stores increased 5.4 percent. Walgreens Balance® Rewards loyalty program reached 82 million active members at the end of this year’s fourth quarter.

“Our fourth quarter performance was in line with our expectation, recognizing we have much more to do. We closed the fiscal year by exercising the option for the second step of our strategic transaction with Alliance Boots, completing the transition of our pharmaceutical distribution to AmerisourceBergen and driving continued improvement in our daily living business that resulted in our largest year-over-year quarterly and fiscal-year sales increases in three years,” said Walgreens President and CEO Greg Wasson. “While continuing to work through pharmacy margin pressure, we were able to achieve improved top-line pharmacy growth as our retail pharmacy market share for the fiscal year increased 30 basis points to 19.0 percent. Finally, we maintained solid expense control in the fourth quarter and are moving forward with the implementation of our previously announced cost-reduction initiative to achieve $1 billion in savings by the end of fiscal 2017.”

For earnings history and earnings-related data on Walgreens (WAG) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Management Comments, Retail Sales

Related Entities

Earnings